Derek M. Winstanly, MBChB currently serves as Board Chair of Renovion, a Biophamaceutical Company based out of Durham, NC and Board Member of Huya, a Biophamaceutical Company based out of San Diego, CA. He previously served as the Executive Vice President, Chief Customer and Governance Officer of Quintiles Transnational, November 2011- 2015. In addition, his responsibilities included Government Affairs, Head of Compliance, Office of Chief Medical Officer and Chair of the Asia Pacific Regional Board. Dr. Winstanly joined Quintiles in 1999 as President of Quintiles Japan and was responsible for the implementation of the Asia Pacific Contract Pharmaceutical Organization, including Pre-clinical, Clinical, Commercial, Academy, and Informatics divisions. In 2002, he became Chairman of Quintiles Japan and Regional Director for the Asia-Pacific Region. In June 2005, he became the Executive Vice President, Strategic Business Partnerships and Chief Customer Officer. He also has a special interest in patient empowerment and social media and their impact on clinical development. Prior to joining Quintiles, Dr. Winstanly worked for Glaxo Wellcome, plc, now GlaxoSmithKline, for 15 years. Dr. Winstanly first joined Glaxo South Africa, now Glaxo-SmithKline South Africa, as Medical Director in charge of Clinical Development, Regulatory and Medical Affairs. After being named and serving as Chief Executive Officer of the South African company, Dr. Winstanly moved to the U.K. to accept the position of Director, Migraine & New Therapy areas, where he was responsible for the International Commercial development of all products in these disease areas. Following the merger of Glaxo, Inc. and Burroughs, Wellcome & Co., he was appointed President of Nippon Wellcome, now Glaxo-SmithKline K.K., in Japan. Dr. Winstanly qualified as a Medical Doctor MBChB at the University of Pretoria and is registered as a Medical Practitioner in both the U.K. and South Africa. In addition, Dr. Winstanly also flew as a pilot with the South African Airforce and completed a certificate course in Aviation and Space Medicine both in Farnborough, UK and the Institute of Aviation Medicine in South Africa.